Announcements Trials

Browse Landscape

Phase

Phase NA 2 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6 Pain 3 Pain, Postoperative 2 Agnosia 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Postoperative Complications 1 Ovarian Cysts 1 Neoplasms 1 Malignant Neoplasms of Male Genital Organs 1 Intraoperative Complications 1 Goiter 1 Colorectal Neoplasms 1 Chronic Pain 1 Carcinoma, Renal Cell 1 Advanced Ovarian Cancer 1 Abdominal Neoplasms 1

Interventions

Fluorouracil 131 Leucovorin 127 Oxaliplatin 93 Bevacizumab 86 Irinotecan 74 Capecitabine 63 Cetuximab 47 Folfox protocol 32 Panitumumab 18 regorafenib 16 trifluridine tipiracil drug combination 15 Drug Therapy 14 Chemotherapy, Adjuvant 13 IFL protocol 10 Floxuridine 10 Radiotherapy 9 Tegafur 7 Neoadjuvant Therapy 7 Levoleucovorin 7 Laparoscopy 7 Aspirin 7 pembrolizumab 6 atezolizumab 6 Trifluridine 6 Celecoxib 6 XELOX 5 Mitomycin 5 Colonoscopy 5 tipiracil 4 sintilimab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colorectal Neoplasms × Ropivacaine × Clear all

NCT01318161 2021-02-16

EPICOL

Örebro University, Sweden

Phase 3 Terminated

Gastrointestinal

Pain, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡